Cargando…

Fremanezumab for migraine

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: NPS MedicineWise 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186266/
https://www.ncbi.nlm.nih.gov/pubmed/32346217
http://dx.doi.org/10.18773/austprescr.2020.016
_version_ 1783526912234094592
collection PubMed
description
format Online
Article
Text
id pubmed-7186266
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher NPS MedicineWise
record_format MEDLINE/PubMed
spelling pubmed-71862662020-04-28 Fremanezumab for migraine Aust Prescr New Drugs NPS MedicineWise 2020-03-03 2020-04 /pmc/articles/PMC7186266/ /pubmed/32346217 http://dx.doi.org/10.18773/austprescr.2020.016 Text en (c) NPS MedicineWise 2020 http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND) 4.0 License.
spellingShingle New Drugs
Fremanezumab for migraine
title Fremanezumab for migraine
title_full Fremanezumab for migraine
title_fullStr Fremanezumab for migraine
title_full_unstemmed Fremanezumab for migraine
title_short Fremanezumab for migraine
title_sort fremanezumab for migraine
topic New Drugs
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186266/
https://www.ncbi.nlm.nih.gov/pubmed/32346217
http://dx.doi.org/10.18773/austprescr.2020.016